Medical Director, Cancer Services Baystate Regional Cancer Program Baystate Health
Oncology
Dr. Wilson C. Mertens, MD
|
|
Give Review
Wilson Mertens practices Oncology. He has 16 awards "Best Doctors in America ", "Meaningful Use Stage 1 Certification", "Cambridges Whos Who", "Emeralds Whos Who", "Breath of Life", "National Discovery", "VISTA Award", "Marquis Whos Who in America", "Annual Teaching Award, Family Practice Residency", "Alpha Omega Alpha", "Continuing Scholarship", "Studentship", "Faculty Association Award", "Wells Award in Chemistry", "London Academy of Medicine Award" and "Foundation Academic Award". Wilson Mertens is a published doctor and has 37 publications published. The lastest was: 'Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic Leukemia: report of two cases.
- Does therapeutic touch ease the discomfort or distress of patients undergoing stereotactic core Breast biopsy? A randomized clinical trial.
- Longitudinal patterns of weight gain after breast Cancer diagnosis: observations beyond the first year.
- Can a Cancer program-sponsored spiritual event meet with acceptance from patients and other attendees?
- Association of admission date with Cancer patient survival at a regional hospice: utility of a statistical process control analysis.
- Contralateral breast Cancer: factors associated with stage and size at presentation.
- Taking a "leap of faith": acceptance and value of a Cancer program-sponsored spiritual event.
- Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guide...
- Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung Cancer progressing after platinum-based chemotherapy: a multicenter phase II ...
- Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate Carcinoma metastatic to bone: a preliminary report.
- Adjuvant chemotherapy for soft tissue sarcomas.
- Differential aspects of sleep epilepsy.
- Osteosarcoma and other Tumors of bone.
- Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapy.
- Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficacy.
- Strontium 89 therapy and relief of pain in patients with prostatic Carcinoma metastatic to bone: a dose response relationship?
- Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal Cell carcinoma.
- Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
- Glutathione S-transferase expression in renal Cell carcinoma: a new marker of differentiation.
- Adjuvant chemotherapy of soft tissue sarcomas.
- Utility of 111In-labelled leukocytes in patients completing high-dose interleukin-2 therapy: a pilot study.
- Soft tissue sarcoma in adults.
- Adjuvant chemotherapy in the treatment of soft-tissue sarcoma.
- Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced Malignant melanoma: a phase II study.
- Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.
- High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets.
- Adenocarcinoma of the eccrine sweat Gland: response to both combination chemotherapy and local field irradiation.
- Oral indomethacin and ranitidine in advanced Melanoma: a phase II study.
- Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts.
- Metastatic melanoma from intraocular primary Tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials.
- Effect of indomethacin plus ranitidine in advanced Melanoma patients on high-dose interleukin-2.
- Prognostic significance of Cellular proliferation in renal Cell carcinoma: a comparison of synthesis-phase fraction and proliferating Cell nuclear antigen index.
- Phase II study of sulofenur (LY186641) in measurable metastatic renal Cancer.
- Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate Cancer: feasibility and preliminar...
- Glutathione sulfhydryl transferase-pi expression in testicular germ-Cell tumors - an immunohistochemical study of 30 cases.
- Formally defining medical processes.
Schools
Schulich School Of Medicine At The University Of Western Ontario
University Of Western Ontario
Baystate Health Medical Director Cancer Services Baystate Regional Cancer Program
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- Best Doctors in America ®
- Meaningful Use Stage 1 Certification
- Cambridge’s Who’s Who
- Emerald’s Who’s Who
- Breath of Life
- National Discovery
- VISTA Award
- Marquis’ Who’s Who in America
- Annual Teaching Award, Family Practice Residency
- Alpha Omega Alpha
- Continuing Scholarship
- Studentship
- Faculty Association Award
- Wells Award in Chemistry
- London Academy of Medicine Award
- Foundation Academic Award
Education
-
University of Western Ontario
Drug Facts
| NPI NUMBER | 1427016484 | |
| NPPES Provider LastName | MERTENS | |
| NPPES Provider FirstName | WILSON | |
| NPPES Provider ZIPCode | 01199 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 284.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 69.0 | |
| Percent Opioid Claims | 24.3 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427016484 |
| Last Name Of The Provider | MERTENS |
| First Name Of The Provider | WILSON |
| View All |
Similar Doctors
|
|
Dr. Deborah Katz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Armen Asik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masih U. Farooqui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Hetzel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip T. Glynn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankit J. Kansagra, MD
This Doctor is OpenDoctor Recommended.
|